Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYMS | P04818 | 4/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | TK1 | P04183 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TYMP | P19971 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17844996 | 1.00 | TYMS (0.45) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL887563 | 0.94 | TYMS (0.44) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL19500417 | 0.92 | TYMS (0.44) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL14286636 | 0.88 | TYMS (0.48) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL5064823 | 0.88 | TYMS (0.48) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL8159110 | 0.88 | TYMS (0.46) | TYMSTK1TYMP | |
| SCHEMBL8166332 | 0.86 | TYMS (0.47) | TYMSTK1TYMP | |
| SCHEMBL4814982 | 0.84 | TYMS (0.44) | TYMSTYMP | |
| SCHEMBL3088129 | 0.83 | CYP1A2 (0.60) | TYMSCYP1A2CYP3A4TSHRTK1 | |
| SCHEMBL28636366 | 0.83 | TYMS (0.30) | TYMS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3234132-A1 | LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS | Dicerna Pharmaceuticals, Inc. (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2016100401-A1 | LIGAND-MODIFIED DOUBLE-STRANDED NUCLEIC ACIDS | DICERNA PHARMACEUTICALS, INC. (US) | 2016-06-23 | — | — | WO | disclosed |